Metabolism of plant-derived anticancer agents.
Cragg
G
G
Natural Products Branch, National Cancer Institute, Bethesda, Maryland 20892.
Suffness
M
M
D000818:Animals; D000972:Antineoplastic Agents, Phytogenic / Q000378:metabolism* / Q000494:pharmacology; D002478:Cells, Cultured; D004341:Drug Evaluation; D004353:Drug Evaluation, Preclinical; D004611:Ellipticines / Q000378:metabolism / Q000494:pharmacology; D005900:Glaucarubin / Q000031:analogs & derivatives / Q000378:metabolism / Q000494:pharmacology; D006248:Harringtonines / Q000378:metabolism / Q000494:pharmacology; D006801:Humans; D011034:Podophyllotoxin / Q000378:metabolism / Q000494:pharmacology; D011763:Pyrrolizidine Alkaloids / Q000378:metabolism / Q000494:pharmacology; D036702:Quassins
D000972:Antineoplastic Agents, Phytogenic; D004611:Ellipticines; D006248:Harringtonines; D011763:Pyrrolizidine Alkaloids; D036702:Quassins; C013095:indicine-N-oxide; D005900:Glaucarubin; D011034:Podophyllotoxin; C002550:bruceantin